Aethlon Medical, Inc.

NasdaqCM:AEMD Stock Report

Market Cap: US$4.5m

Aethlon Medical Future Growth

Future criteria checks 0/6

Aethlon Medical's revenue and earnings are forecast to decline at 171.5% and 6.6% per annum respectively while EPS is expected to grow by 29% per annum.

Key information

-6.6%

Earnings growth rate

29.0%

EPS growth rate

Medical Equipment earnings growth16.1%
Revenue growth rate-171.5%
Future return on equityn/a
Analyst coverage

Low

Last updated04 Mar 2024

Recent future growth updates

Recent updates

We're Keeping An Eye On Aethlon Medical's (NASDAQ:AEMD) Cash Burn Rate

Aug 02
We're Keeping An Eye On Aethlon Medical's (NASDAQ:AEMD) Cash Burn Rate

FDA approves protocol change in Aethlon's trial of its purifier to treat severe COVID

Jul 11

We're Keeping An Eye On Aethlon Medical's (NASDAQ:AEMD) Cash Burn Rate

Mar 18
We're Keeping An Eye On Aethlon Medical's (NASDAQ:AEMD) Cash Burn Rate

We're Interested To See How Aethlon Medical (NASDAQ:AEMD) Uses Its Cash Hoard To Grow

Nov 09
We're Interested To See How Aethlon Medical (NASDAQ:AEMD) Uses Its Cash Hoard To Grow

Aethlon Medical climbs on Reddit interest

Jun 09

We're Keeping An Eye On Aethlon Medical's (NASDAQ:AEMD) Cash Burn Rate

May 12
We're Keeping An Eye On Aethlon Medical's (NASDAQ:AEMD) Cash Burn Rate

We're Hopeful That Aethlon Medical (NASDAQ:AEMD) Will Use Its Cash Wisely

Jan 27
We're Hopeful That Aethlon Medical (NASDAQ:AEMD) Will Use Its Cash Wisely

Aethlon Medical has a new business and medical chief

Jan 06

Aethlon Medical (AEMD) rockets 63% as FDA amends Hemopurifier IDE for COVID-10 treatment

Dec 16

Aethlon names Charles J. Fisher, Jr., M.D. as CEO

Nov 03

Earnings and Revenue Growth Forecasts

NasdaqCM:AEMD - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/2025N/A-13N/AN/A3
3/31/2024N/A-13N/AN/A3
12/31/20231-12-11-11N/A
9/30/20231-12-10-10N/A
6/30/20231-12-11-10N/A
3/31/20231-12-11-11N/A
12/31/20220-13-12-11N/A
9/30/20220-13-12-11N/A
6/30/20220-11-11-10N/A
3/31/20220-10-10-10N/A
12/31/20210-9-9-9N/A
9/30/20211-9-9-8N/A
6/30/20211-9-8-8N/A
3/31/20211-8-7-7N/A
12/31/20201-7-6-6N/A
9/30/20201-6-5-5N/A
6/30/20201-6-5-5N/A
3/31/20201-6-5-5N/A
12/31/20191-6-5-5N/A
9/30/20190-7-5-5N/A
6/30/20190-7-5-5N/A
3/31/20190-6-4-4N/A
12/31/20180-6-4-4N/A
9/30/20180-5-4-4N/A
6/30/20180-5-4-4N/A
3/31/20180-6-4-4N/A
12/31/20170-6-4-4N/A
9/30/2017N/A-6N/A-4N/A
6/30/20170-7N/A-4N/A
3/31/20170-7N/A-4N/A
12/31/20161-7N/A-4N/A
9/30/20161-7N/A-4N/A
6/30/20161-6N/A-4N/A
3/31/20161-5N/A-4N/A
12/31/20151-5N/A-5N/A
9/30/20151-5N/A-6N/A
6/30/20151-4N/A-5N/A
3/31/20151-7N/A-5N/A
12/31/20141-13N/A-4N/A
9/30/20141-14N/A-3N/A
6/30/20141-17N/A-3N/A
3/31/20142-13N/A-2N/A
12/31/20131-9N/A-2N/A
9/30/20131-6N/A-2N/A
6/30/20131-4N/A-2N/A
3/31/20131-5N/A-2N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: AEMD is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: AEMD is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: AEMD is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: AEMD is forecast to have no revenue next year.

High Growth Revenue: AEMD is forecast to have no revenue next year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if AEMD's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.